(Q79956903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Michael Amon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Xavier Ligneau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jean-Claude Camelin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Isabelle Berrebi-Bertrand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jean-Charles Schwartz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Holger Stark

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

708-716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

The Sequence of the Human Genome

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Drug discovery: a historical perspective

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

The histamine H3 receptor: from gene cloning to H3 receptor drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Synthesis of potent non-imidazole histamine H3-receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Fluorescent probes for proteolysis: tools for drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Fluorophore-tagged GPCR ligands.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Fluorescent ligands, antibodies, and proteins for the study of receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Single-molecule spectroscopic methods

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Single-molecule fluorescence studies of protein folding and conformational dynamics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Synthesis and pharmacological activity of fluorescent histamine H1 receptor antagonists related to mepyramine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Synthesis and pharmacological activity of fluorescent histamine H2 receptor antagonists related to potentidine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Fluorescent ligands for the histamine H2 receptor: synthesis and preliminary characterization

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600270

7 January 2021

Identifiers

DOI

10.1002/CMDC.200600270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17361979%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference